Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Alto Neuroscience Inc.
IPO Date: February 2, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $69.58M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.34 | 4.03%
Avg Daily Range (30 D): $0.09 | 3.51%
Avg Daily Range (90 D): $0.10 | 4.04%
Institutional Daily Volume
Avg Daily Volume: .28M
Avg Daily Volume (30 D): .19M
Avg Daily Volume (90 D): .2M
Trade Size
Avg Trade Size (Sh.): 106
Avg Trade Size (Sh.) (30 D): 133
Avg Trade Size (Sh.) (90 D): 121
Institutional Trades
Total Inst.Trades: 68
Avg Inst. Trade: $1.64M
Avg Inst. Trade (30 D): $1.39M
Avg Inst. Trade (90 D): $1.26M
Avg Inst. Trade Volume: .17M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.39M
Avg Closing Trade (30 D): $3.88M
Avg Closing Trade (90 D): $2.32M
Avg Closing Volume: 348.46K
   
News
Jul 23, 2025 @ 2:00 PM
INVESTOR ALERT: Pomerantz Law Firm Investigates Cl...
Source: Pomerantz Llp
Jul 22, 2025 @ 10:49 PM
ALTO CLASS ACTION ALERT: Bragar Eagel & Squire, P....
Source: Bragar Eagel & Squire, P.C.
Jul 22, 2025 @ 10:25 PM
ALTO NEUROSCIENCE, INC. (NYSE: ANRO) INVESTOR ALER...
Source: Bernstein Liebhard Llp
Jul 22, 2025 @ 8:00 PM
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
Jun 3, 2025 @ 6:48 PM
Alto Neuroscience Adds 'Intriguing' Depression Ass...
Source: Vandana Singh
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-2.34 $-.56 $-.56
Diluted EPS $-2.34 $-.56 $-.56
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -63.18M $ -15.17M $ -15.2M
Operating Income / Loss $ -69.9M $ -15.68M $ -17M
Cost of Revenue $ $ $
Net Cash Flow $ -44.64M $ -7.48M $ -13.47M
PE Ratio